NFKB1 and atherosclerosis: These effects, in turn, suppress the activity of AP-1 and NF-κB and reduce the production of inflammatory cytokines, growth factors, and adhesion molecules that induce inflammation, thrombogenesis, atherosclerosis and angiogenesis.